Treatment of Streptococcal Toxic Shock Syndrome: First-Line Protocol

Streptococcal toxic shock syndrome (STSS) demands immediate, aggressive intervention. The first-line protocol addresses the infection directly while supporting failing organs and, where relevant, managing necrotizing soft tissue involvement.

Affected patients commonly present in haemodynamic shock with progressive multi-organ failure. Necrotizing fasciitis or myositis may accompany the systemic picture, each component requiring a distinct but coordinated response.

The cornerstone of treatment is high-dose parenteral antibiotic therapy, with a second agent added specifically for its anti-toxin effect. Surgical debridement is a required element when necrotizing soft tissue infection is confirmed. Concurrent organ support measures are part of the full regimen — access the complete protocol for the structured approach, agent selection, and clinical decision framework.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1186/s13613-018-0438-y3/cid/ciu296

Penicillin G is bactericidal and remains, at high parenteral doses, the first-line treatment for infections due to SGA.
Clindamycin, a lincosamide antibiotic, is usually added to penicillin or aminopenicillin since it inhibits the protein synthesis by blocking the 50S sub-unit of the bacterial ribosome.
Only surgical debridement of infected and necrotic tissues associated with high-dose systemic antibiotic therapy may improve mortality.
In case of necrotizing fasciitis and/or myositis, this aggressive surgical approach is the only one that may help stabilize the patient and save his life.
Antibiotic therapy should be given rapidly, associating high doses of parenteral beta-lactams plus clindamycin for its "anti-toxin" effect.

View source ↗